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Abstract 
One out of four people age 65 and older residing in a long term care facility (LTCF) has Type 2 
diabetes (T2DM) (Smide & Nygren, 2013). Care and management of this population is a 
challenge for nurses and other providers. Results of a needs assessment in a local LTCF 
identified deficiencies in the provision of evidence-based T2DM care for this target population. 
American Diabetes Association Guidelines (2017) recommend application of individualized 
HbA1c targets for the elderly residing in LTCFs, especially for those with compromises in 
clinical and functional status. This two-prong quality improvement project strove to educate 
nurses about these residents’ needs, and incorporate the use of best practice diabetes standards in 
the nurse practitioner’s practice. Specifically, emphasis was placed on HbA1c and finger stick 
monitoring, eye exams, and foot care. Results indicated that educational in-services designed for 
nurses were an effective approach to improving knowledge concerning care of complex TD2M 
patients. Although ophthalmology and podiatry referrals were not ordered routinely because of 
APRN, staff, and organizational resistance; utilization of standardized orders improved routine 
T2DM care pertaining to ordering HbA1c, renal panel, and urine to albumin creatinine ratio. The 
APRN now has the awareness to evaluate discrepancies between HbA1c results and finger stick 
values. QI projects in LTCF’s may be difficult to implement and sustain related to staff turnover, 
understaffing, high patient acuity, and organizational and provider opposition. APRNs must 
advocate for continual utilization of evidence-based practice guidelines for all LTC residents. 
Keywords: Type 2 diabetes, long term care facility, American Diabetes Association Guidelines 
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Overview of the Problem 
The burden of diabetes is staggering. The Centers for Disease Control (CDC, 2014) report 
that in all age categories, approximately 29.1 million (9.3%) of the U.S. population is touched by 
diabetes; which includes the people diagnosed (21.0 million) and undiagnosed (8.1. million) with the 
disease. Diabetes was the seventh leading cause of death in 2011 and cost the U.S. $176 billion in 
direct costs and $69 billion in indirect costs. Indirect costs include disability, work loss, and 
premature death (Jones et al., 2014).  
The CDC (2015a) asserts that for the last 34 years (1980-2014), there has been a sustained 
increase in the number of Americans diagnosed with type 2 diabetes (T2DM) (5.5 million to 22 
million). By age, the prevalence of T2DM in Americans aged 65 and older was reported at 11.2 
million (diagnosed and undiagnosed) or 25.9% of the U.S. population (American Diabetes 
Association [ADA], 2017b). The number of new cases was reported at 400,000 per year in 2012 at 
an unadjusted rate of 11.5 persons per 1,000 new cases (CDC, 2015b). 
 The Administration on Aging (2016) cited that in 2014, the proportion of the U.S. population 
aged 65 years and older accounted for 46.2 million, which represented 14.5% of the U. S. population 
(one in every seven Americans). The period between 2004-2014 indicated that the number of 
Americans who will reach the age of 65 over the next two decades is estimated to rise to 17.7% 
while those aged 60 and over will increase from 48.9 to 64.8 million (32.5%). Life expectancy rates 
for persons reaching the age of 65 have also lengthened an additional 19.3 years (20.5 years for 
females and 18 years for males). Projected estimates calculate that a child born in 2014 may live to 
78.8 years, which is 30 more years than a child who was born in 1900. This immense explosion of 
the aging population is of critical significance in nursing and healthcare because diabetes mellitus 
affects over 20% of people over the age of 65 (Huang, 2016, p. 1). 
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For the state of Texas, data from the Texas Department of State Health Services (2016) 
indicates that the unadjusted prevalence rate of diabetes for Texas residents was at 11% (derived 
from a total population of 26,448,193) and it was found to be more common in Hispanics than 
whites. The annual age-adjusted death rates for all ages per 100,000 persons attributable to diabetes 
was recorded at 5,262 and was more than twice as likely to occur in blacks than whites. Hispanics 
were twice as likely to die from diabetes as whites. The annual age-adjusted hospitalization rate for 
adults 18 years and older with diabetes was reported at 12 per 100,000 adults (95% confidence 
interval) with a total cost burden over $280 million in Medicaid dollars spent (total combines 
inpatient and outpatient care and professional fees) which averages $1,113.62 in reimbursement per 
beneficiary (Texas Department of State Health Services, 2016). 
 Diabetes is a complicated disease. It is complicated by other co-existing conditions and 
complications including hypoglycemia, hyperglycemia, hypertension, hyperlipidemia, heart disease, 
stroke, blindness and visual problems, kidney disease, amputation, neuropathy, non-alcoholic fatty 
liver disease, periodontal disease, erectile dysfunction, hearing loss, and depression all of which 
makes its management inherently problematic (Jones, Hines, Narva, & Albright, 2014). Of the 
complications previously specified, cardiovascular disease (heart disease or stroke), blindness and 
other eye problems, kidney disease, and lower limb amputations are among the top four diabetes-
related complications. The CDC (2014) reported the number of people in the U.S. age 35 years and 
older with diabetes and self-reported heart disease or stroke rose from 4.2 million to 7.6 million from 
1997-2011. In 2011, 5 million people with diabetes stated having coronary heart disease, 3.7 million 
confirmed having other heart disease or condition, and 2.1 million confirmed having had a stroke. 
The number of adults aged 18 years or older with diagnosed diabetes reporting visual impairment 
from 1997-2011 increased from 2.7 million to 4.0 million. Data regarding the true prevalence 
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estimates of self-reported visual impairment may have been underestimated since approximately 
25% of individuals with diabetes have not been formally diagnosed (CDC, 2014). 
Diabetes-associated chronic kidney disease (CKD) is estimated to affect more than 20 
million adults and was the ninth leading cause of death in the U. S. Overall, the prevalence of CKD 
increased from 12% to 14% between 1988 and 1994. From 1999 to 2004, the rate has remained 
relatively stable (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2016). 
NIDDK (2016) described the largest increase since 1988 (4.5% to 6%) occurred in people with Stage 
3 CKD. From 1980 to 2008, the number of persons initiating treatment for end-stage-renal-disease 
(ESRD) related to diabetes increased from over 2,600 to 48,374 in 2008. However, the rate of new 
cases since 1999 has decreased (CDC, 2014). 
Ortman, Velkoff, and Hogan (2014) cited that T2DM in the elderly is an alarming health 
issue because the elderly population age 65 and older is calculated to double from 43.1 million to 
83.7 million between 2012-2050. This exponential increase has been attributed to the aging baby 
boomers who started turning 65 in 2011 (Ortman et al., 2014). Due to the expansive growth of this 
older adult population, it is anticipated that the utilization of nursing facilities, alternative residential 
care facilities, or home care services will rise from 15 million to 27 million between 2000-2050 
(CDC, 2016). More than two-thirds of this aging population will require some type of long term care 
facility (LTCF) services during their lifetime with a 46% possibility of residing in a nursing home 
(CDC, 2016). 
Data regarding the number of Americans aged 65 and older requiring LTCF services are of 
remarkable significance for health care providers considering that one out of four Americans aged 65 
and older who resides in nursing homes has T2DM and may receive substandard care (Smide & 
Nygren, 2013). Vijan, Sussman, Yudkin, and Hayward (2014) conducted a chart review of 245 cases 
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in 14 extended care facilities and found that the management of T2DM did not meet the 
recommended ADA standards of care for ambulatory adults. The authors also found that despite 
36.7% of the residents meeting the target A1c goal, the effect of glucose variability on the A1c 
results was not accounted for. Likewise, Garcia and Brown (2011) conducted a systematic review of 
literature of 20 studies from six countries (predominantly in the U. S.) regarding the diabetes 
management in nursing homes or long term care settings. The results showed that there were varying 
levels of management practices and adherence to the recommended standards of care for T2DM and 
disease management was sporadic at best. Estimates indicate that the pervasiveness of T2DM in 
LTCFs in the U.S. is at 33.3% for those who are 65 years and older (Vajen et al., 2012). It is 
imperative that health care providers in this arena are properly trained to deliver high quality T2DM 
care. 
Background of the Problem 
 De Fronzo (2009) stated that T2DM is a chronic progressive disease characterized by insulin 
resistance in the muscle and liver with beta cell failure as the central components of the disease 
process (otherwise known as the triumvirate). Patients in the top tiers of impaired glucose tolerance 
and at the highest strata of insulin resistance have over 80% loss of their beta cells which intimate 
that beta cell failure evolves at a much more expeditious and serious rate than previously speculated. 
The aforementioned trifecta is cited as the underlying core defect implicated in the development and 
progression of T2DM but its pathogenesis has now expanded to the paradigm of the Ominous Octet. 
The triumvirate (liver, muscle, and beta cell) now encompass the circuitous involvement of the fat 
cell (accelerated lipolysis), gastrointestinal tract (incretin/deficiency/resistance), alpha cell 
(hyperglucagonemia), kidneys (increased glucose reabsorption), and brain (insulin resistance) in the 
development and progression of T2DM (Figure 1). 
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Figure 1. The Ominous Octet. This figure illustrates the development and progression of T2DM. 
Reprinted from “From the triumvirate to the ominous octet: A new paradigm for the 
treatment of type 2 diabetes mellitus,” by R. De Fronzo, 2009, Diabetes, 58, p. 782. Copyright 2009 
by the American Diabetes Association. 
 
 Care for the elderly with T2DM diabetes mellitus requires special considerations due to age-
related co-morbid complications in this vulnerable group including polypharmacy, decreased renal 
function, high risk for falls, poor vision, and cognitive decline (ADA, 2017a, p. 99). The current 
consensus regarding the treatment goals for the elderly is centered on individualizing glycemic 
targets based on their clinical and functional conditions (ADA, 2017a). The implicit expectation is, 
for those elderly patients who are cognitively and functionally intact and have reasonable life 
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expectancy rates, disease management should be similar to those standards established for younger 
adults (ADA, 2017a). Davis, Wenhui, Meyers, Kilpatrick, and Pandya (2014) noted that several 
organizations have made varying recommendations on the use of alternative Hemoglobin A1c 
(HbA1c) targets for older adults (65 and older) in poor health status (two or more co-morbid 
conditions and functional limitations). The ADA (2017a) advocates a desirable HbA1c target of 
<8.5% for elderly adults in LTCF, while organizations such as the Diabetes Program of Nova Scotia 
in concert with the Palliative and Therapeutic Harmonization program recommend targets be 
adjusted to >8.0% but lower than 12% depending on circumstances that complicate the care. CVAs 
and myocardial infarctions are among the deadly complications associated with hypoglycemia in this 
population. Likewise, the International Association of Gerontology and Geriatrics, the European 
Diabetes Working Party for Older People, along with an international taskforce of diabetes experts 
inferred the desirable HbA1c target for older adults aged 70 or older should be 7.0% -7.5% with 
further relaxation for those who live in LTCF (Davis et al., 2014). For the purpose of this project 
proposal, the 2017 ADA journal supplement Standards of Medical Care in Diabetes (ADA, 2017a) 
is utilized as the benchmark guideline for evaluation of care (Table 1).  
Synopsis of the Microsystem 
To shed some light on the T2DM care of the elderly in LTCFs, a needs assessment was 
conducted in a nursing home in southwest Texas to determine if its elderly residents ages 65 and 
above who had diabetes and other co-morbid conditions and functional limitations were receiving 
age-appropriate diabetes care based on the most current ADA guidelines. The nursing home is a for-
profit, 126 bed LTCF that had an occupancy rate of 86 patients at the time the needs assessment was 
conducted. The facility is nestled within a quiet residential neighborhood and is 8.3 miles away (16  
minutes) from the nearest hospital. The facility is part of a leading healthcare and rehabilitation  
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Table 1 
ADA diabetes treatment guidelines 
_____________________________________________________________________________________ 
Condition    Complication   Frequency 
_____________________________________________________________________________________________ 
Blood glucose control   HbA1c    Every 3 months until the target  
level is reached; thereafter,  
patients should be monitored  
at least every 12 months 
_____________________________________________________________________________________________ 
Foot ulcers    Physical exam focused on  Patients at very high risk 
ankle reflexes, dorsalis  should be seen every 3  
pedis pulse, vibratory sensation,  months by a wound care 
and 5.07 monofilament touch nurse. Patients at increased 
sensation performed by a   risk and average risk should  
provider qualified to   be screened annually 
determine the level of risk for 
foot ulcers 
_____________________________________________________________________________________________ 
Microalbuminuria   Microalbumin/creatinine ratio Annually 
_____________________________________________________________________________________________ 
Retinopathy    Dilated eye exam by a trained Patients with evidence of  
eye services professional or  retinopathy should be screened 
Nondilated digital photography  annually. Patients without evidence 
followed by a comprehensive  of retinopathy should be screened 
exam for those who test positive every 2 years 
_____________________________________________________________________________________________ 
Electrolyte and chemistry   Serum creatinine and serum  At least annually 
abnormalities    potassium 
_____________________________________________________________________________________ 
Note. Retrieved from Diabetes Care. Copyright 2017 by the American Diabetes Association.  
 
service provider for the elderly composed of 19 other LTCFs throughout Texas. The facility 
provides area residents with access to hospice/palliative care, rehabilitation services, respite care, 
skilled nursing services, transitional care, and long term residential care specifically tailored to the 
needs of elderly patients.  
The LTCF is staffed by registered nurses, licensed vocational nurses, medications aides, 
certified nurse aides, a director of nursing, three assistant directors of nursing, a facility 
 INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY                                         17 
 
administrator, rehabilitative services personnel, social workers, activities personnel, administrative 
personnel, (receptionist, admissions coordinator, medical records clerk, and business office staff), 
and other ancillary staff responsible for the day-to day functioning of the LTCFs (housekeeping and 
nutrition services) (Table 2). Staffing needs are dictated by the current census. Nursing related 
personnel are scheduled for 8-hour shifts (6:00 a.m. - 2:00 p.m., 2:00 p.m. - 10:00 p.m., and 10:00 
p.m. - 6:00 a.m.) while the rest of the LTCF staff work from 09:00 a.m. to 5:00 p.m. 
The Federal Nursing Home Reform Act (NHRA), as part of the Omnibus Budget 
Reconciliation Act (OBRA) of 1987 does not provide specific nurse-to-resident staffing ratios for 
registered nurses, licensed vocational nurses, or certified nurse aides as long as there is a registered 
nurse on duty at least eight hours a day, seven days a week (this includes the director of nursing) for 
facilities that have less than 60 residents), seven days a week and a licensed nurse (registered nurse 
or licensed vocational nurse) on duty the rest of the time. There is no required minimum staffing for 
CNAs (National Consumer Voice for Quality Long-Term Care, 2017).  
From a financial standpoint, the facility administrator at the facility communicated that the 
ideal staffing ratio for twenty-two patients is one registered nurse or one licensed vocational nurse 
with a medication aid and a certified nurse aide. Input from the nurses at the facility revealed that 
they are frequently understaffed and overworked, particularly on the weekends. They stated that the 
nurse to patient ratio could be better given the high acuity level of the residents. 
There are three physician group practices that deliver facility-based services to the LTCF. 
The microsystem of interest are the patients assigned under the services of Dr. A. Dr. A. is a DNP 
board certified family nurse practitioner who has been employed by one of the three physician  
practices for approximately six months. The group practice is one of the nation’s leading providers 
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Table 2 
Type of employees in LTCF 
_____________________________________________________________________________________ 
Nursing Staff   Number of Staff   LTCF Staff Description if Applicable 
_____________________________________________________________________________________________ 
RNs    5    1 DON, 1 ADON, 3 staff RNs 
_____________________________________________________________________________________________ 
LVNs    24    2 LVNs who are also ADONs and 2 LVNs  
that Accomplishes Minimum Data (MDS) 
full-time 
_____________________________________________________________________________________________ 
CNAs    38    Full/part-time, and PRN 
_____________________________________________________________________________________________ 




Physical Therapy (PT)  9    5 PTs and 4 PT assistants 
_____________________________________________________________________________________________ 
Occupational Therapy (OT) 6    1 OT and 5 certified OT assistants 
_____________________________________________________________________________________________ 
Speech Therapy (ST)  2    1 ST and 1 ST assistant 
_____________________________________________________________________________________________ 




Facility Administrator  1 
_____________________________________________________________________________________________ 
Human Resources  1 
_____________________________________________________________________________________________ 
Admissions Coordinator  1 
_____________________________________________________________________________________________ 
Business Office   2 
_____________________________________________________________________________________________ 




Receptionist   1 
_____________________________________________________________________________________________ 
Social Worker   1 
_____________________________________________________________________________________________ 
Housekeeping   2 
_____________________________________________________________________________________________ 
Nutrition Services  3    1 registered dietician and 2 dietary aides 
_____________________________________________________________________________________________ 
Note. All staff are hired by the facility 
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of hospital medicine and other related facility-based services. Dr. A. is assigned to a total of three 
LTCFs and is expected to visit skilled nursing care patients three times per week and long term care 
residents every 60 days. This assignment is in addition to attending to acute issues that surface in the 
long term care residents, on-call coverage two to three times per week as well as every other 
weekend on-call coverage for her “pod” (which consists of a physician and two nurse practitioners). 
Dr. A. has an assigned a monthly patient quota of 240 visits per month. Currently, she sees 180 to 
200 patients per month.  
Based on direct observation of the workflow at the LTCF, the facility was frequently short-
staffed, relied heavily on paraprofessional staff (licensed vocational nurse and medication aides), and 
lacked a unit clerk at the nurse’s station, which may have alleviated the burden for licensed 
personnel in answering phone calls, transcribing orders, and filing documentation. Lack of a unit 
clerk contributed to a chaotic environment by not having permanent personnel responsible for 
maintaining the accuracy and security of confidential health records. Laboratory, pharmaceutical, 
and radiology services were provided by outside contractors.  
The providers did not have dedicated office space at the LTCF which was an ongoing 
practice issue. Unnecessary interruptions from patients, staff, and visitors were a frequent 
occurrence. The facility did not have an electronic medical chart system. Dr. A disclosed that most 
of her time was devoted to completing all necessary documentation by hand. There was an enormous 
pressure to meet the 240 visits per month quota along with ensuring that billing and coding was 
submitted in a timely manner for immediate reimbursement. Dr. A stated that the overwhelming 
amount of paperwork and productivity expectations impeded her time and ability to make certain 
that the recommended age appropriate T2DM guidelines for her group of patients were properly 
executed. 
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 Leadership at the LTCF was unstable. The newly hired director of nursing who had been 
there for over one month at the time of the assessment was terminated since she did not attend work 
for two weeks. She did not notify anyone of her absence. Per staff report, this was the second 
director of nursing in eight months. At the time of the needs assessment, the facility administrator  
had only been in the position for over four months and ultimately resigned at the six-month mark. By 
the time the project was implemented, an interim facility administrator was in place and a permanent 
director of nursing had been hired.  
 The facility administrator conveyed that the facility accepts most insurances but Medicare 
and Medicaid are the predominant payers that provide coverage for their residents. Medicare 
reimburses at a rate of $475 per day, while Medicaid reimbursement is at a rate of $167 per day. 
Private pay patients are also accepted at a rate of $4500 per month for semi-private rooms and $9000 
per month for private lodging. The facility does accept patients pending Medicare or Medicaid 
approval; but if funding falls through, the facility will absorb the financial loss. Services for the 
residents such as food, medications, radiology or laboratory services are bundled into this fee. 
Provider visits and off-site consultations are independently billed by the providers. Figure 2 for a 
breakdown of the mentor’s patients according to payor source.  
The clinical assessment data was collected using a personal interview involving the following 
healthcare personnel: one Advanced Practice Registered Nurse (APRN), four registered nurses 
(which includes one director of nursing, one assistant director of nursing, and two staff registered 
nurses), and eight licensed vocational nurses. These personnel were purposefully selected for the 
loosely structured interview since they were acquainted with the day-to-day care of the elderly 
residents with T2DM with co-morbid conditions in the LTCF (target population). The participants 
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were asked if they were aware of what the desirable HbA1c targets were for their population 
(Appendix A). They were reassured that there was no right or wrong answer and that the 
 
Figure 2. Payer types at the LTCF. Of the 16 mentor patient charts reviewed, 9 patients were 
Medicaid recipients, 4 were Private Pay, 2 were Medicare, and 1 was pending Medicare or Medicaid 
funding.  
 
purpose of the interview was to determine their baseline knowledge and identify any potential 
deficiencies that may need to be corrected with education. Inquiry regarding the appropriate HbA1c 
targets for the elderly effortlessly transitioned to the next question, which was: Are you familiar with 
the diabetes treatment guidelines pertaining to periodic monitoring of complications associated with 
T2DM? See Appendix A for the complete list of questions. Responses received from the nurses 










Types of Insurance at the LTCF 
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T2DM care of the target population. For example, the nurses were not able to specify the frequency 
as to when routine blood draws associated with T2DM management need to be ordered. 
Use of the key informant approach was the technique utilized in garnering more detailed 
information from the APRN, director of nursing, and facility administrator. These people were 
identified as the leaders, stakeholders, and key decision makers who were knowledgeable about the 
policies and procedures of the facility. Key informants are valuable in the manner that they are able 
to accurately identify priority needs and concerns regarding the care of the target population (Iowa 
State University, 2017). A confidential discussion with the APRN revealed several barriers that 
prevented her from achieving the best care possible for the target population such as ordering off-site 
consultations for ophthalmology and podiatry services. Difficulties in ensuring routine surveillance 
for the other complications associated with T2DM were also communicated.  
The primary issue hindering the APRN from accomplishing this task was described as 
“competing priorities”. Minimal information was garnered from the director of nursing at the facility 
since that employee had been at the facility for just over one month. The facility administrator at the 
facility was helpful in providing information about the regulations surrounding the management of 
nursing home facilities and the billing/reimbursement practices for this predominantly Medicare 
and/or Medicaid covered group. 
An existing data approach was used to determine the deficiencies in the care of the target 
population. A census list of the patients exclusively assigned to Dr. A’s services was obtained.  
Recommendations to exclude patients admitted for long term acute care, hospice/palliative care, 
rehabilitation services, and respite care was abided by since these patients were at the facility for a 
short duration of time. A medical demographic sheet was created to record information about the 
patient’s demographic variables, HbA1c results, and co-morbid conditions (Appendix B). This was 
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later expanded to include information on the frequency of ophthalmology and podiatry visits and 
routine laboratory values associated with T2DM care. As previously mentioned, the facility does not 
have an electronic medical record system. Data was manually extracted from the charts. No patient 
identifiable information was collected or recorded.   The chart audit revealed that the top five 
medical diagnoses were type 2 diabetes mellitus, coronary artery disease, dementia, chronic renal 
failure and dementia. Anonymity of the patients was maintained using coded numbers; no names 
were used. 
 The face-to-face interview with the APRN revealed that she was aware that the target HbA1c 
should be above 7.0% for the target population but she was unable to provide details on the factors 
that dictated the need for individualization. The APRN reported that HbA1c results on the chart were 
taken at face value without further investigation of its concordance with the finger stick blood 
glucose values. There are contributing factors that may cause a discordance with the HbA1c values 
particularly for those patients that have conditions that impact the turnover of red blood cells such as 
low hemoglobin/hematocrit values (causes for HbA1c to be lower), iron deficiency anemia (causes 
HbA1c to be higher), or recent blood transfusions (HbA1c result is reflective of donor’s HbA1c 
value). The HbA1c results has its limitations since it is an indirect measure of the average glycemic 
control for the past three months. For these patients, the best indicator for glycemic variability are 
the finger sticks (ADA, 2017a, p. 48). The value of the HbA1c needs to be reviewed in conjunction 
with the glucometer readings (finger stick results) to evaluate appropriate diabetes management and 
to determine if the frequency of the finger sticks is sufficient (ADA 2017a, p. 48).   
 The director of nursing at the facility was unsure of what the HbA1c targets were. The 
response received was “I know it should be higher.” The assistant director of nursing and one 
licensed vocational nurse stated that it should be between 4%-5%, while the seven licensed 
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vocational nurses and two staff registered nurses openly acknowledged “I don’t know” adding that if 
the results fell within the recommended ranges specified on the laboratory results sheet the patient’s 
HbA1c was considered “under control.” 
 Medical records were reviewed to obtain further data about the microsystem. Sixteen out of 
thirty-seven charts reviewed at the facility were eligible for inclusion (65 years of age and above 
with T2DM and not admitted for hospice/palliative, skilled nursing services, rehabilitation, acute 
care, or respite care). The median age of the included patients was 75 years old (67-94 years old) 
(Figure 3) and consisting of eleven males and five females. Age distribution was broken down as  
  
Figure 3. Age distribution of participants. This figure illustrates the age distribution of project 
participants. 
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The median HbA1c level for these patients was calculated at 6.7% (range was from 5.1%-
10.5%). HbA1c ranges were established at <7.0%, 7.0%-7.5%, 7.5%-80%, and >8.0; corresponding 
to 11, 2, 1, and 2 patients). Three of the medical records did not have the HbA1c test ordered. The 
HbA1cs were generally lower than the recommended individualized target for this population 
(Figure 4). 
 
Figure 4. HbA1c levels of 16 project patients. This figure illustrates the HbA1c breakdown 
percentage of 16 patients.  
 
The 16 patient records included for evaluation in this project had more than one co-morbid 
condition (see figure 5). Dementia (12 out of 16 patients) and the presence of macrovascular 
complications such as cerebrovascular accidents/transient ischemic attack (nine patients), coronary 
artery disease (10 patients), congestive heart failure (three patients), and peripheral vascular disease 
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LTCF had a documented diagnosis of CKD with two patients receiving hemodialysis three times per 
week (Figure 5).  
  
Figure 5. LTCF co-morbid conditions. This figure depicts the co-morbid conditions present amongst 
the 16 project patients.  
 
Pertaining to routine T2DM care, the APRN indicated that since she has been there for six 
months, has not ordered any ophthalmology or podiatry referrals for any of the patients. Reportedly, 
she was informed by the APRN who oriented her that off-site referrals for these services were not 
seen as necessary since the patients were “on their way out.” She later acknowledged that the leading 
factor for not ordering the referrals was dependent on allowed services specific to each resident’s 
healthcare insurance carrier. For example, Medicaid will pay for an annual optometry visit for 
eyeglasses (coverage for this service is optional) but not for a dilated diabetic retinal exam 
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glaucoma treatment and not for an annual diabetic retinal exam. The remainder of the charts (12) did 
not have ophthalmology visits recorded in the progress notes.  
Among the 16 patient records, only five podiatry visits were noted on the charts and four of 
these were ordered at the request of the patient or the patient’s family. The director of nursing  
disclosed that there is a podiatrist that comes to the facility but only to address specific problems 
and/or a request made by the staff. Once a patient is seen, the podiatrist becomes a listed service 
provider for the patient for routine checks provided there is a predisposing condition that justifies the 
visit. For Medicaid recipients, podiatry services may not be covered, but Medicare beneficiaries may 
be eligible for examination and treatment of the feet every six months when there is a documented 
diagnosis of diabetic sensory neuropathy and loss of protective sensation (Department of Health and 
Human Services [DHHS], 2010). Otherwise, routine T2DM care involving retinal examinations and 
foot checks were not done on the patients seen by the APRN. 
The rates of compliance pertaining to routine laboratory checks for HbA1c, albuminuria, and 
renal function studies were low. Current ADA Standards of Medical Care in Diabetes stipulate 
quarterly HbA1c checks in patients who are not meeting glycemic targets and annual assessment of 
urinary albumin to creatinine ratio and renal function tests for diabetic kidney disease surveillance 
(ADA, 2017a). For the 16 patient records reviewed, HbA1c levels were ordered at a frequency of 
every month to six months. There were no microalbuminuria studies found on any of the charts; 
while renal function studies were ordered every other day, to weekly, or five months later. Dr. A. has 
acknowledged that the patient load demand, increased patient acuity, and expectations set by her 
employer play a critical factor in her inability to provide appropriately individualized T2DM care for 
the elderly patients assigned to her “pod”. 
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Strengths identified at the LTCF were: (1) the APRN awareness about the issues restricting 
proper T2DM care for her assigned patients; (2) committed APRN receptiveness to improving 
T2DM care for her group of patients; (3) assistant director of nursing amenable to staff education 
and dedicated to residents’ needs; (4) strong commitment by facility administrator to improve care 
and quality of life for residents, and (5) demonstration of staff willingness to work together to 
achieve a common goal. 
Weaknesses identified included: (1) APRN assignment to three nursing homes limited the 
provider’s time to ensure individualized T2DM care; (2) APRN decisions to order ophthalmology or 
podiatry referrals influenced by management; (3)  healthcare staff’s (registered nurses and licensed 
vocational nurses)  knowledge deficit regarding evidenced-based T2DM care guidelines; (4) the 
need to modernize information system technology (i.e. electronic records); (5) facility administrator 
views healthcare from finance perspective – business demands of healthcare viewed as priority 
issue; (6) fragmentation of documentation due to contracted laboratory services; (7) unstable LTCF 
leadership; and (8) rapid staff turnover rate. Identification of the strengths and weaknesses available 
for certain opportunities and threats for the QI project implementation are illustrated in Table 3.  
Significance of the Problem 
 Use of the Dartmouth Clinical Microsystem Assessment tool (Dartmouth College, 2008) 
unmasked numerous deficiencies at the LTCF. It revealed that there was poor communication and 
teamwork amongst the staff, potential understaffing, rapid staff turnover, unstable leadership, the 
absence of a centralized electronic medical record and most importantly, non-adherence to ADA 
recommendations for certain patients. These identified problems significantly impact the 
individualized care of older adults with diabetes who reside in LTCFs. 
 
 INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY                                         29 
 
Table 3 
Opportunities and threats for QI project implementation
_____________________________________________________________________________________________ 
Opportunities      Threats 
_____________________________________________________________________________________________ 
*     healthcare staff is given the leadership role   *     increasing health care costs resulting in falling  
       to address geriatric health issues           revenue for the facility 
*     there is potential to formally coordinate how   *     reduced funding from Medicare & Medicaid 
       routine T2DM care services are rendered  *     misinformation about T2DM care for the 
*     improve patient safety through individualized                 elderly 
       T2DM care for the elderly    *     lack of electronic medical records system 
*     collaborative effort to address the deficiencies   *     too much management intervention 
       ensure comprehensive T2DM care          regarding limiting costs 
*     increased awareness of evidence-based practice  *     limited reimbursement for nursing homes 
*     collaborative health improvement effort addressing  *     older and sicker patients 
       routine T2DM care may lower complications and  *     information overload for the staff 
       hospitalization rates 
*     standardization will prevent duplication of services 
_____________________________________________________________________________________________ 
Note. Sample strengths and weaknesses for the implementation of the QI project.  
 
 Dimensions addressed during the implementation of the quality improvement (QI) program 
included: (1) the healthcare team’s lack of familiarity with the modified HbA1c targets for the 
elderly proposed by the most current ADA guidelines (Table 4); (2) the types of co- morbid 
conditions prevalent in the target population, the number of elderly patients who do not have 
individualized HbA1c targets that take into consideration their age and co-morbid conditions; and 
(3) ensuring that monitoring of conditions and complications associated with T2DM.  
Hausken and Graue (2012) note the glaring discrepancies within the ADA’s 
recommendations versus the true-to-life care of institutionalized elderly patients with T2DM patients 
in poor health conditions. High quality evidenced-based care is lacking in the treatment and care of 
this population due to the inadequate training of health care staff driven by the rising number of 
diabetes cases among those age 65and older admitted to LTCFs with complex medical needs and 
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complicated treatment regimens (Hausken & Graue, 2012). Similarly, Smide and Nygren (2013) 
identified discernible gaps in levels of diabetes knowledge when LTCFs health care workers were 
presented with a case study regarding the proper care of an elderly patient with T2DM. 
Table 4 
HbA1c targets in older adults with T2DM 
_____________________________________________________________________________________________ 
Patient characteristic/health  Rationale   Reasonable HbA1c target goal 
status 
_____________________________________________________________________________________________ 
Healthy (few con-existing chronic  Longer remaining  <7.5% (58 mmol/mol) 
illnesses, intact cognitive and   life expectancy 
functional status 
_____________________________________________________________________________________________ 
Complex/intermediate (multiple  Intermediate remaining  <8.0% (64 mmol/mol) 
coexisting chronic illnesses or 2+  life expectancy, high 
instrumental activities of daily  treatment burden, 
living impairments or mild to  hypoglycemia 
moderate cognitive impairment  vulnerability, fall risk 
_____________________________________________________________________________________________ 
Very complex/poor health (LTC or  Limited remaining life  <8.5% (69 mmol/mol) 
end-stage chronic illnesses or  expectancy makes benefit  
moderate to severe cognitive  uncertain 
impairment or 2+ activities of daily 
living dependencies 
_____________________________________________________________________________________________ 
Note. Framework for considering treatment goals for glycemia. Adapted from “Standards of medical 
care in diabetes – 2017,” by ADA, 2017, Diabetes Care, 40(1), p. S101. Copyright 2017 by the 
American Diabetes Association.  
 
Individualization of HbA1c targets in the elderly with T2DM and co-morbidities is of 
paramount importance because inappropriately tight glycemic targets can predispose this 
compromised group to a myriad of preventable complications such as diabetic retinopathy, diabetic 
kidney disease, diabetic peripheral neuropathy, and foot ulcers (ADA, 2017a). Routine screening for 
CKD and diabetic retinopathy; the two major microvascular complications associated with T2DM 
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needs to be emphasized. Urine albumin to creatinine ratio (UACr) and declines in glomerular 
filtration rate (eGFR) are the best clinical indicators of renal function status (ADA, 2017a). A study 
by Rodriguez-Poncelas et al. (2016) showed that CKD, elevated UACr and/or presence of declining 
GFR was associated with the development and progression of diabetic retinopathy. Benetos et al. 
(2013) note that a comprehensive ophthalmological examination that incorporates visual acuity, 
dilated-eye slit-lamp examination, and retinography is critical in the timely identification and 
treatment of diabetic retinopathy to minimize visual loss.   
Purpose of the Project 
 The primary aim of the project was to improve the delivery of routine T2DM care in the 
elderly with comorbid conditions at one LTCF by having the APRN increase her knowledge of and 
follow an order set following the 2017 ADA Standards of Medical Care in Diabetes guidelines and 
increasing nursing staff’s knowledge of diabetes care for this population. A change in the provider’s 
ordering practice using a checklist sheet and standardized order sheet was intended to prevent and/or 
delay the progression of diabetes-related complications, to ensure safer care, to preserve functional 
abilities, to promote independence, and to maintain or improve quality of life for this susceptible 
population (ADA, 2017a). 
            The secondary aim of the project was to educate the registered nurses, and licensed 
vocational nurses regarding applicable 2017 ADA Standards of Medical Care in Diabetes evidence-
based guidelines related to the treatment of elderly patients with T2DM with co-morbid conditions. 
Through the educational one-on-one in-services, it was communicated that tight glycemic control is 
not applicable for the elderly with complex health conditions and that although major goal of tight 
glycemic targets is to prevent long term complications, it is more pertinent for healthy and younger 
older adults (<65 years old) who have an additional life expectancy of at least 10 more years.  
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Review of Literature Evidence 
Question Guiding Inquiry (PICOT) 
          Does the implementation of an evidenced-based diabetes toolkit improve the individualization 
of HbA1c targets and routine T2DM care in elderly patients with T2DM complicated by co-morbid 
conditions and functional limitations who reside in LTCF?  
Benchmarking 
In healthcare, benchmarking is the process of comparing an organization’s key performance 
measures against nationally-recognized best practices, targets, or goals (Kay, 2007). For this quality 
improvement project, the 2017 ADA Standards of Medical Care in Diabetes were used as the 
reference point for the evidence-based delivery of care for the target group. For the last 25 years, the 
ADA has steadfastly developed and distributed diabetes care standards, guidelines, and other related 
documents. Healthcare professionals tasked with the care of patients with diabetes have come to 
view the ADA Standards of Medical Care in Diabetes, position statements, and scientific statements 
as the blueprint for clinical decision making (ADA, 2017a). 
Methodology (Search Strategy) 
            A literature search of relevant literature was performed from January 2015 to September 
2017. Searches were made in the following databases: CINAHL, EBSCOHost, Medline, NCBI, 
PubMed, PubMed Central, and ScienceDirect. Search terms included “American Diabetes 
Association guidelines,” “co-morbidities,” “diabetes,” “diabetes related knowledge,” “diabetes 
management,” “elderly,” “evidenced-based diabetes management,” “geriatric,” “gerontology,” 
“individualized care,” “long term care,” “modified HbA1c target,” “nursing home,” “older adults,” 
“older people,” “routine diabetes care,” and “type 2 diabetes.” The search terms were used for all 
fields (including title, abstract, keywords and full text). Searches were limited to English-language 
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peer-reviewed journals published in the last five years. The initial literature search yielded 22,098 
peer reviewed articles on the topic. The final number of articles considered was 33. Other materials 
referenced were association reports, government websites, and society transactions. 
Critique and Synthesis of Research Findings 
To establish the evidence base for the recommended appropriate glucose control in the 
elderly, 10 intervention articles published in English were examined. The studies predominantly 
involved elderly adults with T2DM using various glucose lowering agents (GLA) to achieve 
intensive glucose control. Three recurring themes were identified from the selected articles (Table 
5). All 10 articles investigated the effect of advancing age, co-morbid conditions, and what role the 
type of GLA therapy selected contributes to the incidence of hypoglycemic events. 
Table 5 
Identified themes from different evidence sites 
                            Theme Authors 
Survival rates, role of various GLA 
therapies in inciting hypoglycemia, 
associated T2DM complications, and 
mortality rates in the elderly with co-
morbid conditions. 
Claesen et al. (2016); Fang et al. (2013); 
Huang et al. (2014); Lee et al. (2011); Lipska 
et al. (2015); Pilotto et al. (2014); Roumie et 
al. (2016); Tseng et al. (2014); Vijan et al. 
(2014); and Yau et al. (2012). 
Guideline implementation for glycemic 
control in the elderly with T2DM. 
Lee et al. (2011); Yau et al. (2012); Tseng et 
al. (2014); Vijan et al. (2014); and Yau et al. 
(2012).  
Risks and benefits of intensive glycemic 
control in the elderly and its outcomes. 
Fang et al. (2013); Lee et al. (2011); Lipska et 
al. (2015); Pilotto et al. (2014); Roumie et al. 
(2016); Tseng et al. (2014); Vijan et al. 
(2014); and Yau et al. (2012). 
      Note. Articles describing factors contributing to the incidence of hypoglycemic events. 
Caution regarding the use of sulfonylurea with or without insulin in the elderly with co-
morbid conditions was emphasized due to the following issues associated with aging: decreases in 
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hepatic and renal function affecting drug metabolism and clearance, dampened autonomic response 
to hypoglycemia, alterations in the presentation of symptoms, distortion in glycemic margins, 
heightened hypoglycemia unawareness, existence of multiple co-morbidities, and rampant 
polypharmacy (Jafari & Britton, 2015). Of significance is presentation of cardiovascular (CV) 
complications associated with T2DM (myocardial infarction and ischemic stroke) as the co-morbid 
condition that places elderly persons at highest risk for hypoglycemic events. Intensive glycemic 
control predisposes the elderly to fatal cardiac arrhythmias due to the prolongation of the QT interval 
brought about by catecholamine release as a response to hypoglycemia (Jafari & Britton, 2015).  
           Recommendations to adhere to the guidelines relaxing HbA1c targets based on life 
expectancy, functional, status, and patient preference were discussed in 5 out of the 10 articles 
(Claesen et al., 2016; Huang et al., 2014; Lipska et al., 2015; Pilotto et al., 2014; & Vijan et al., 
2014). The consensus in 8 out of the 10 articles that the target HbA1c need to be individualized in 
the elderly population due to their compromised health status (Huang et al., 2014; Lee et al., 2011; 
Lipska et al., 2015; Pilotto et al., 2014; Roumie et al., 2016; Tseng, Soroka, Maney, Aron, & 
Pogach, 2014; Vijan et al., 2014; & Yau et al., 2012). Treatment goals for the elderly with T2DM 
need to be focused on preventing poor outcomes, maintaining quality of life, preventing injuries such 
as falls, and guaranteeing continued independence if possible (Pilotto et al., 2014; & Yau et al., 
2012). 
            Six out of 10 articles selected were retrospective studies (Fang et al., 2013; Huang et al., 
2014; Lipska et al., 2015; Pilotto et al., 2014; Roumie et al., 2016; & Tseng et al., 2014) that 
involved data extraction from healthcare expenditure records (National Alliance of Christian 
Mutualities, The Kaiser Permanente Northern California Diabetes Registry, and Veterans Health 
Administration Database) or derived from other large studies (National Health and Nutrition 
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Examination Survey and Metabolic Study). Huang (2016) noted that older patients with T2DM have 
been consistently excluded from large scale prospective clinical diabetes trials due to the inherent 
difficulties associated with their management. He cited two trials that attempted to accomplish this 
difficult task. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) attempted to 
investigate the effect of intensive glycemic management in patients over the age of 80 but the high 
rates of hypoglycemic events that occurred after the participants were randomized into the 
intervention arms led to the revision of the study protocol to exclude patients over 80 years old 
(Huang, 2016). Likewise, researchers in the Japan Elderly Diabetes Intervention trial involving 
1,173 patients were unable to evaluate a multiple risk factor intervention in patients aged 65-85 years 
due to treatment related hypoglycemic events in older patients (Huang, 2016). The remainder of the 
articles were small scale prospective studies (Fang et al., 2013; Lee et al., 2011; & Yau et al., 2012) 
and a simulation study (Vijan et al., 2014). Although small and simulated, it provided substantial 
information on other selected outcomes such as micro/macrovascular complications, functional 
outcomes, and quality of life issues. Overall, all 10 articles selected had the goal of providing 
targeted care management in the elderly. Care for the older patient with T2DM revolves around 
weighing the risks and benefits of tight glycemic control in this vulnerable group (Huang et al., 
2014; Lee et al., 2011; Lipska et al., 2015; Roumie et al., 2016; Tseng et al., 2014; Vijan et al., 2014; 
& Yau et al., 2012). 
Limitations (Literature Gaps) 
          Kirkman et al. (2012) asserted that despite the pervasiveness of diabetes in older adults aged 
65 years and older, particularly those with co-morbid conditions and functional limitations, they 
have mostly been excluded from randomized controlled trials due to the complexity in their health 
conditions. Benetos (2013) noted that the overall dearth of evidence-based guidelines specific to the 
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management of diabetes in the elderly who reside in nursing homes is due to the heterogeneity of 
this population with regards to comorbidities, polymedication, and frailty. Anderson’s (2014) 
national audit of 2,043 nursing homes reinforced that significant gaps in the care of these residents 
existed. Specifically, 63% of the homes audited lacked a representative accountable for diabetes 
management and 33% of homes lacked direct access to training materials supportive of diabetes care 
(Anderson, 2014). Findings from the Institute of Diabetes in Older people has created a push to 
provide better education and training for nurses and stricter governance to providing high-quality 
evidence-based care. 
Methodology 
Design (Intervention Strategy) 
This two-pronged quality improvement project aimed to increase the APRN’s (provider) 
knowledge and utilization of the ADA Standards of Medical Care in Diabetes – 2017 guidelines and 
to educate staff nurses on current evidence-based practice for LTCF residents with diabetes. For the 
APRN provider, a one-on-one review on the 2017 ADA Standards of Medical Care in Diabetes 
pertaining to the importance of adherence to the recommended diagnostic and therapeutic actions in 
the prevention and management of diabetes complications for the target population was 
accomplished on June 5, 2017. Emphasis was placed on the modified HbA1c targets for elderly 
patients with T2DM with co-morbid conditions and functional limitations. Recommendations to 
implement an individualized HbA1c target based on the risk to benefit ratio was presented via a 
handout (Appendix C). There was an emphasis that lower HbA1c goals for the target population was 
not necessarily better and aggressive control in patients with advanced diabetes and heart disease 
was not warranted. 
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The strengths and limitations of the HbA1c test as an accurate representation of the patient’s 
average glucose was explored with the provider. It was highlighted that the HbA1c is not a perfect 
test. Examples of conditions that can cause a discordance between the HbA1c and mean glycemia 
were presented (Appendix D). The main talking point here was that hemoglobin and red blood cell 
pathologies renders the accuracy of the HbA1c as a potentially unreliable biomarker for glycemic 
control (ADA, 2017a, p. 50).  Lastly, the routine T2DM checklist and standardized order sheet 
(Appendices E & F) developed with the input of the provider was incorporated into the charts of 
those patients who met the inclusion criteria to remind the provider when to order the recommended 
tests/procedures. 
Exclusively for the provider, a pocket sized printed HbA1c glucose value converter was 
presented (Appendix G). Included in it were the conditions that can falsely lower HbA1c results, 
particularly clinical conditions that can shorten erythrocyte life span or decrease mean erythrocyte 
age. The primary purpose of the information sheet was to alert the APRN provider that HbA1c 
results may not accurately reflect glycemic control when clinical conditions that affect erythrocyte 
survival are present (ADA, 2017a). The expectation was that the provider would pursue 
investigation of those conditions that may cause discrepancies between HbA1c results and daily 
glucose values to enable the provision of timely patient interventions. With regards to 
individualization of HbA1c targets, the provider was encouraged to annotate on the progress notes 
the appropriately individualized HbA1c for the target population based on the ADA 2017 Standards 
of Medical Care in Diabetes guidelines (Table 1). Annotation of the modified HbA1c target on each 
patient’s chart may ensure that optimal care is delivered since this serves as form of communication 
for other providers who may be responsible for the care of the patient in other circumstances.  
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Education for the APRN was planned according to Dayal and Alvarez’s (2015) attestation 
that standardized order sets facilitated improved compliance with recommended evidenced-based 
standards of care while simultaneously ensuring appropriate resource utilization and delivery of cost-
effective quality care. To improve compliance with the required routine T2DM care, a concise 
checklist and standardized order sheet was adapted from the 2017 ADA Standards of Medical Care 
in Diabetes and added into the chart to avoid oversight of the crucial elements in the prevention of 
complications associated with T2DM. The purpose of the checklist was to improve efficiency by 
prompting the healthcare staff and provider when certain screenings and assessments were due to be 
ordered (Appendix E&F) and establish that none of the required routine care for T2DM was 
overlooked. Although it was not a part of the QI implementation project, information regarding 
annual lipid checks and the routine required immunization checks were included in the checklist and 
standardized order sheet per discussion with the project coordinator to ensure that the other 2017 
ADA Standards of Medical Care in Diabetes could be met. 
For the nursing staff, the plan for the intervention strategy was to provide a one-one-one in-
service program that educated the healthcare staff on the most current evidenced-based guidelines 
promulgated by the ADA in 2017. Specifically, the education intervention was intended to improve 
compliance with routine T2DM care for the target population. With permission from the LTCF 
management, a one-one-one in-service with the use of informational handouts was delivered in mid-
June 2017 at a time that was convenient for the RNs/LVNs. The plan was to educate 80% of the 
nurses (23 out of 29) on all three shifts. The one-on-one in-service was conducted in a private 
conference room free of interruptions. The in-service provided a brief yet concise presentation of the 
most current evidence-based guidelines regarding the appropriate care and importance of 
individualized HbA1c targets in elderly patients with T2DM complicated by complex conditions 
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(Appendix C, D, & L). A checklist (Appendix E) and simplified standardized order sheet (Appendix 
F) was distributed to the 13 participants. Its potential value in improving the care of the target 
population was highlighted.  
Setting and Sample Plan 
          The location of the QI program implementation project was a LTCF located in southwest 
Texas. Due to staff time constraints, the sampling strategy chosen for the education in-service was a 
non-probability convenience sampling. This sampling plan allowed for the evaluation of the 
effectiveness of the in-service education in a relatively fast and inexpensive manner (Lund Research 
Limited, 2012). For the patient medical record audit, the sampling strategy chosen was the non-
probability purposive sampling method. The aim of the project was to evaluate data from a 
homogeneous sample, that is, a group of elderly patients 65 years and older with T2DM and co-
morbidities who resided in a LTCF. A homogeneous sampling strategy was deemed appropriate for 
this project since the PICOT question that was addressed specifically targeted the attributes of the 
group of interest (Lund Research Limited, 2012).  
Stakeholder Involvement 
            A stakeholder is anybody who can affect or is affected by an organization, strategy or project 
(Morphy, 2017). Involvement of the stakeholder, whether an individual or a group is crucial in 
achieving improved outcomes for the target group. For the LTCF, the stakeholders were the APRN 
provider, management, healthcare staff, and patients. The APRN provider was supportive in the 
development and planning of the QI project. Dr. A. provided substantial input on how to develop the 
standardized orders to ensure that the best outcomes were achieved for the patients. Likewise, 
support from management was obtained providing that it would not interfere with the healthcare 
staff’s workflow and not cost the facility undue overtime costs. A suggestion from the facility 
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administrator was to conduct the in-service during the LTFC’s planned monthly staff meeting. 
Ultimately, this strategy was not feasible due to an unplanned state inspection during the week the 
in-service was planned. Instead, the registered nurses and licensed vocational nurses were 
approached on a one-on-one basis at a time that was convenient for them. Interest by the healthcare 
staff in the QI project was shown by their desire to learn the current evidenced-based guidelines 
regarding the appropriate care of the target population during the microsystem needs assessment. 
Nurses specifically requested an in-service about the topic. Although the patients were not directly 
involved in the QI project, the outcome of the process and results of the effort could have a 
significant impact in their care. It was essential that Dr. A., the LTCF’s management, and its staff 
were actively involved in the quality improvement program and intervention. Education, checklists, 
and standardized order sheets that were specifically designed in the care of the target population 
provided an increased opportunity for positive for the target population. 
IRB Considerations 
 The process of obtaining an informed consent from the nurses or patients was not necessary 
as no hands-on patient healthcare interventions was performed. The proposed project plan was a QI 
strategy and did not involve direct patient care. Chart audits were kept confidential with no 
identifying information recorded. The records were stored securely in a locked file cabinet in 
compliance with the LTCF, university, and federal guidelines pertaining to the protection and 
confidentiality of the participants’ identifiable information as mandated by the Health Insurance 
Portability and Accountability Act of 1996 (HIPAA). University of the Incarnate Word IRB exempt 
status approval was obtained, as well as a letter of support from the LTCF in lieu of IRB approval 
due to the facility’s lack of an established IRB. Additionally, a letter of support for the completion of 
the project was obtained from the LTCF. 
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Evaluation Model 
            The New World Kirkpatrick Model (Kirkpatrick Partners, 2017) was the evaluation model 
selected for the implementation of the quality improvement program at the LTCF. It is the updated 
version of Kirkpatrick’s original four levels of training evaluation. A brief explanation of the 
updated Kirkpatrick model is as follows: 
1. Level I: Reaction. This level seeks to determine how much the participants are actively  
involved in the learning process and what their contributions are into the learning  
experience (engagement). It includes and inquiry regarding the pertinence of the training  
learned on the job (relevance) (Kirkpatrick Partners, 2017). 
2. Level II: Learning. This level measures the efficacy of the training and if the objectives 
were accomplished based on five criteria: knowledge (“I know it”), skill (“I can do it right 
now”), attitude (“I believe this will be worthwhile to do on the job”), confidence (“I think I 
can do it on the job”), and commitment (“I intend to do it on the job”). 
3. Level III: Behavior. This level evaluates the participant’s on-the-job use of the training 
they received and incorporates factors (processes and systems) that strengthen, facilitate, 
and positively reward performance of the crucial behaviors required to accomplish the job 
(required drivers).  
4. Level 4: Results. This level examines the tangible outcomes of the training and the 
presence of short-term indicators that ensure that crucial elements in performance of the job 
are consistently being applied to achieve the desired outcomes.  
            Kirkpatrick’s New World Evaluation model is beneficial in the methodical discovery of   the 
quality improvement’s (QI) value, quality, and significance based on a set of established criteria. 
Evaluation of the Kirkpatrick evaluation model was considered throughout the design, development, 
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and implementation of the QI project and brought to light problems that existed within the 
organization. For example, the nurses were not aware of the current ADA guidelines pertaining to 
the care of the elderly who reside in nursing homes. This information enabled the clarification and 
refinement of those issues along the way. The suitability of the Kirkpatrick evaluation model in the 
evaluation of the education in-service and T2DM routine checklist served as an unbiased measure of 
the projects efficacy at each of the essential levels (Kirkpatrick Partners, 2017). It was identified as 
the most appropriate evaluation model for the program implementation since the effectiveness of the 
training program needed to be measured.  
 
Objectives and Timeline 
I. By June 15, 2017, 100% of the provider (one provider) and 80% of the RNs/LVNs (23 
out of 29) at the LTCF will: 
a) Able to identify the current guidelines that exists for treating diabetes in  
elderly patients following a one-on-one evidence-based educational in-service  
presentation. 
b) Able to identify the issues that need to be considered in individualizing  
treatment recommendations for elderly patients. 
c) Be familiarized and proficient with the use of the routine T2DM checklist and  
standardized order sheet for T2DM routine care.  
II. By July 30, 2017, after implementation of the educational in-service and T2DM  
routine checklist, the APRN provider will: 
a) Improve the individualization of HbA1c targets in elderly patients with T2DM  
complicated by complex medical conditions and functional limitations. 
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b) Use the standardized order sheet that delineates the recommended test/procedures  
for routine T2DM care on a consistent basis. 
c) Pursue investigation of underlying conditions that may cause discordance  
between the HbA1c and finger stick glucose values. 
III. By July 30, 2017, after implementation of the educational in-service and T2DM  
routine checklist, 80% of the healthcare staff will: 
a) Recognize the importance of routine T2DM care in the prevention/delay of  
diabetes related complications. 
b) Use the routine T2DM checklist consistently in elderly patients with T2DM 
complicated by complex medical conditions and functional limitations. 
IV. By September 30, 2017, 80% of the elderly residents at the LTCFs with T2DM  
complicated by co-morbidities and functional limitations will: 
a) Have appropriately individualized HbA1c targets. 
b) Have routine T2DM tests/care ordered according to the recommendations set  
forth by the 2017 ADA Standards of Medical Care. 
Evaluation Plan 
            The evaluation tool for the QI project were derived from the 2017 ADA Standards of 
Medical Care in Diabetes and were adapted to fit the specific needs of the LTCF. The tools 
(Appendix H & I) have not been tested for reliability and validity but have been formulated by 
leading authorities in the field of endocrinology (ADA, 2017a). The information used to adapt the 
questionnaire for the nurses and the checklist were free of charge and easily accessible online; 
therefore, free of copyright restrictions regarding its use and duplication. To evaluate the impact of 
the nursing educational program implementation, a pre- and post-test questionnaire was administered 
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to those nurses who took part in the in-service (Appendix H). The pre- and post-test served as a 
direct evaluation of the participants’ learning and it quantified the extent of the participant’s baseline 
knowledge about the topic before the presentation and assessed the amount of learning achieved 
thereafter (Boston University, n.d.).  
Data Analysis Plan 
            A checklist was developed (Appendix J) to guide the formal post-intervention medical record 
audit. The purpose of the chart audit was to systematically determine the outcomes of the QI 
program implementation (Duke University, 2016). A baseline and post QI project implementation 
chart audit was performed. Twenty-two charts that met the following criteria were included in the 
post-intervention audit: Patients 65 years of age and above with T2DM and not admitted for 
hospice/palliative care, skilled nursing services, rehabilitation services, acute care, or respite care 
were included. The following information was collected by August 1, 2017 and evaluated by 
September 15, 2017 to determine the effectiveness of the QI project: 
1) Routine T2DM laboratory tests (HbA1c, urine albumin to creatinine ratio, serum  
creatinine and GFR) ordered per the 2017 ADA Standards in Medical Care in  
Diabetes guidelines. 
2) Routine T2DM physical exams (eye exam and foot exam) ordered per the  
      guideline recommendations. 
3) Individualized HbA1c targets set for the target population and were they  
annotated on the progress notes. 
4) Clinical conditions contributing to discrepancies on HbA1c results and  
finger sticks further investigated? 
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               Data from the pre/post-test questionnaires (Appendix H), program feedback evaluation 
(Appendix I), and chart audits (Appendix J) were collected. To analyze the results of the pre/post-
test questionnaires and as a measure of the outcomes of the nursing education in-service, the number 
of correct answers were totaled and divided by the total number of questions. Then a mean score was 
calculated and pre- and post-test results were compared. Results from the questionnaires remained 
anonymous. A code number was assigned to each nurse’s questionnaire so that pre- and post-
education questionnaires could be matched for statistical testing. Nurses did not sign their names to 
the questionnaires. The timeline for project completion is depicted in a Gantt chart (Appendix K).   
Results 
Analysis of Data 
 The 22 medical records that met the inclusion criteria for the QI project and were reviewed 
for analysis of project objectives included 13 females and nine males (Table 6). The age composition 
of the residents and racial makeup are included in the table. The racial composition was 
predominantly Hispanic 82% (n=18). The clinical characteristics of the sample were burdened with 
multiple co-morbidities that significantly impacted their functional status. For the whole patient 
population (all age groups), the top five common co-morbidities were chronic kidney disease/end 
stage renal disease (77%), dementia (64%), coronary artery disease (77%), cerebrovascular accident 
(45%), and peripheral vascular disease (9%). The mean HbA1c was at 7% (SD = 1.38) minus one 
that was identified as missing during the pre-implementation chart review. Functional status level 
specifying the patient’s ability to manage activities of daily living such as basic self-care eating, 
bathing, dressing, toileting, transferring, and continence) and instrumental activities of living 
(managing money, shopping, telephone use, travel in community, housekeeping, meal preparation,  
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Table 6 
Characteristics of residents with diabetes selected for the QI project. 
_____________________________________________________________________________________________ 
Categories       Number of Residents 
_____________________________________________________________________________________________ 
Gender 
Male          9 
Female         13 
_____________________________________________________________________________________________ 
Age 
65-75          8 
76-85          7 
86-95          5 
>96          2 
_____________________________________________________________________________________________ 
Race 
Hispanic        18 
Caucasian         4 
_____________________________________________________________________________________________ 
Co-morbidities 
CKD/ESRD        17 
Dementia        14 
Coronary artery disease       14 
Cerebrovascular accident       10  
Peripheral vascular disease       2 
_____________________________________________________________________________________________ 
HbA1c 
<7.0         12 
7.0-7.5          2 
7.5-8.0          3  
>8.0          4 
Missing          1 
_____________________________________________________________________________________________ 
Functional Status 
Dependent        20 
Partially dependent        2 
Independent         0 
_____________________________________________________________________________________________ 
Healthcare carrier 
Medicaid        19 
Medicare         1 
Private pay         2 
_____________________________________________________________________________________________ 
Note. This table depicts characteristics of the 21 residents included in this study. 
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and taking medications as prescribed) were collected from the intake sheets (University of Michigan 
Medical School, 2003). The predominant payer type for healthcare coverage was Medicaid (86%). 
Results of Findings Corresponding to Objectives 
            For the first objective, the target was to provide one-on-one educational in-services to the 
APRN provider and 80% (23 out of 29) of the nurses.  This goal was achieved with the provider 
(100%) but only 13 (45%) of the nurses. Unforeseen circumstances such as rapid staff turnover, 
short staffing, high patient acuity, patient emergencies, and unannounced state inspections hampered 
nursing participation. The nurses were approached for the in-services at a time that was convenient 
for them without interfering or compromising patient care as requested per the administration. A pre-
test consisting of 10 questions was administered at week one to determine baseline knowledge 
followed by a post-test at week two and week four. The respondents consisted of an APRN, three 
RNs, and nine LVNs.  
 Results of the pre-assessment showed a significant deficiency in the diabetes-related  
knowledge regarding the care of LTCF residents with T2DM. The top three missed questions from 
the pre-test assessment (Table 7) were regarding individualization of HbA1c targets in the elderly 
(question # 6 and #7) and the recommended HbA1c goal for most patients set forth by the ADA 
(question #2). At post-test #1, results almost mirrored that of the pre-test; with the top three missed 
questions as being the recommended HbA1c goal for most patients by the ADA (question #2) as the 
most missed, followed as a tie by individualization of HbA1c targets in the elderly (question #6) and 
priority of care for older adults (question #10). By post-test #2, the top three missed questions were 
regarding individualization of HbA1c targets (question #7), conditions that increase hypoglycemia in 
older adults (question #8), followed as a tie by question #6 (HbA1c individualization) and question # 
3 (mortality risk for elderly patients with non-individualized HbA1c targets).  Overall, results of the 
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total scores indicated a significant improvement in diabetes-related knowledge specific to the care of 
the target population (Figure 6). The differences in scores by type of nurse is illustrated in Figure 7.  
Table 7 
Most missed questions from the pre/post-test Questionnaires  
Type  Question Missed 
_____________________________________________________________________________________________ 
   Question #6: What would be a reasonable HbA1c goal for a 72-year-old woman with a 
   Complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100 to  
150 mg/dL? 
Pre-test   Question #7: What would be a reasonable HbA1c target for an older patient with  
                history of recurrent hypoglycemia, limited life expectancy, multiple co-morbid  
conditions, advance chronic kidney disease, and history of strokes? 
Question #2: The HbA1c goal for most patients recommended by the ADA should be at? 
_____________________________________________________________________________________________ 
   Question #2: The HbA1c goal for most patients recommended by the ADA should be at? 
   Question #6: What would be a reasonable HbA1c goal for a 72-year-old woman with a    
Post-test #1  Complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100 to  
150 mg/dL? 
Question #10: The priority or care for older adults with T2DM is the avoidance and  
prevention of? 
_____________________________________________________________________________________________ 
   Question #7: What would be a reasonable HbA1c target for an older patient with a  
history of recurrent hypoglycemia, limited life expectancy, multiple co-morbid  
conditions, advance chronic kidney disease, and history of strokes? 
Question #8: Which of the following conditions increases the risk of hypoglycemia in  
older adults? 
Post-test #2  Question #6: What would be a reasonable HbA1c goal for a 72-year0old woman with a  
complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100-150 
mg/dL? 
Question #3: Elderly patients with complex conditions are at what mortality risk with  
tight blood sugar control? 
_____________________________________________________________________________________________ 
Note. Selected LTCF nursing personnel participated in pre- and post-questionnaires.  
 
For the second objective, the provider was expected to individualize the HbA1c targets for 
each patient that met the inclusion criteria, use the standardized order sheets that delineated the 
recommended test/procedures for routine T2DM care, and pursue investigation of underlying 
conditions that may have caused a discordance between the HbA1c and finger stick glucose values.  
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Figure 6. Results of the total scores from the pre/post-test questionnaires. This figure depicts the 
comparison results determining the level of understanding obtained between the pre- and post-tests.  
 
Figure 7. Differences in total test scores by type of nurse. This figure depicts the test score 












Results of Pre/Post Test Questionnaires















Pre-test Pre-test #1 Pre-test #2
Test Score Differences
APRN 3 RNs (total score out of 30) 9 LVNs (total score out of 90)
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The APRN was assisted with setting individualized HbA1c targets for each patient as noted 
in Table 8. There was 100% incorporation of the standardized order sheets into the charts.  
Table 8 
Individualized HbA1c targets set for each patient 
_____________________________________________________________________________________________ 
HbA1c Target       Number of Patients 
_____________________________________________________________________________________________ 
   <7.5%           2 
     7.5%-8.0%        4 
   <8.0%         4 
     8.0%                     12 
_____________________________________________________________________________________________ 
Note. The table represents the individualized HbA1c target for the APRN’s patients.   
 
However, of the 22 patients, only two patients had the individualized HbA1c annotated in the 
progress notes (Figure 8). With regards to the APRN pursuing discordant HbA1c values, six of the 
HbA1cs were identified as inaccurate. Five were further pursued to investigate the underlying 
condition contributing to the discrepancy and one was missed (Figure 9). Because the HbA1c results 
did not correlate with the patient’s daily finger stick glucose variability, the APRN provider ordered 
further laboratory testing (complete blood count and iron panels) to determine the exact pathological 
process contributing to the discordance. Conditions such as blood loss or hemolytic anemia can 
falsely lower HbA1c results due to the shortened life span of the erythrocyte. Conversely, conditions 
that contribute to increased erythrocyte survival such as iron deficiency anemia influence the 
reliability of the HbA1c as a measure of glycemic control (ADA, 2017a, p. 50).  
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Figure 8. HbA1c modified target annotation in the progress notes. This figure illustrates the notation 
of modified HbA1c targets found in the 22 selected patient’s progress notes. 
 
Figure 9. HbA1c accuracy. This figure illustrates the HbA1c accuracy for the 22 inclusive patient 
chart audit.  
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For objective three, the goal was for 80% (23 out of 29) of the nurses to recognize the 
importance of routine T2DM care in the prevention/delay of diabetes related complications and to 
use the routine T2DM checklist consistently in the selected LTCF residents. As previously discussed 
only 13 (45%) of the nurses were able to participate in the in-services. Knowledge regarding the 
importance of routine T2DM was assessed through a pre/post-test questionnaire with the results 
cited in Figure 6 and 7. Similar to the standardized order sheets, there was 100% incorporation of the 
checklists into the charts. The nurses’ knowledge regarding routine T2DM care of the target 
population improved from a total score of 76 (pre-test) to 85 (post-test #1), and 100 points (post-test 
#2). 
Lastly, for the final objective, the goal was for 80% of the 22 patients to have appropriately 
individualized HbA1c targets and have routine T2DM laboratory tests (HbA1c, urine albumin to 
creatinine ratio, serum creatinine, and GFR) and physical exams (eye exam and foot exam) ordered 
according to the recommendations set forth by the 2017 ADA Standards of Medical Care in 
Diabetes. All the patients (100%) had an individualized HbA1c target annotated on the footnote of 
the routine T2DM care checklist; but, the APRN provider was only able to annotate two in the 
progress notes (Figure 8). Pertaining to routine T2DM test/care the chart audit indicated results were 
as follows: there were 13 HbA1cs due to be ordered; 12 were ordered and 1 was missed (Figure 10); 
only one renal panel was due and it was ordered (Figure 11); and five of the UACrs were due and 
were all ordered (Figure 12). Among the unforeseen outcomes identified was that some of the labs 
that were not due to be done and were inadvertently repeated. None of the foot or ophthalmology 
exams were ordered as anticipated in all 22 patients. A favorable outcome was that the HbA1c, urine 
albumin/creatinine, serum creatinine, and GFR were now triggered to be routinely ordered for all 22 
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patients. Of note, the planned program evaluation was unable to be analyzed. The nurses did not 
return any of the participant feedback forms which may have been the result of questionnaire fatigue. 
 
Figure 10. Breakdown of HbA1c tests from chart audit. This figure illustrates the breakdown of 
HbA1c tests obtained from the 22 inclusive patient chart audit. 
 
Figure 11. Breakdown of renal panels form chart audit. This figure depicts the breakdown of renal 
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Figure 12. Breakdown of UACrs from chart audit. This figure depicts the breakdown of urine 
albumin/creatinine from the 22 inclusive patient chart audit 
 
Discussion and Conclusions 
Elderly patients with T2DM complicated by co-morbid conditions have higher rates of 
morbidity and mortality compared to their younger counterparts. Intensive glycemic targets raise this 
risk even further (ADA, 2017a). Results from the pre-test assessment revealed that there was a 
general lack of awareness on what the appropriate HbA1c targets were for this population. This 
finding provided verification that education on what the current ADA diabetes guidelines are was a 
priority for the nursing staff. Similar concerns were raised by Hausken and Graue (2012) in that 
there was significant need for nurses to be educated in the appropriate management of T2DM 
patients who reside in LTCFs. The in-services provided a means of emphasizing that the goal of 
treatment was to maintain quality of life, preserve independence, and minimize the risk of 
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death. Improvement in the overall total questionnaire scores indicated that knowledge regarding this 
type pf care was increased. The QI project confirmed that a program specifically designed to 
improve professional competence for nurses who care for T2DM patients in LTCFs is an effective 
approach to improving knowledge. 
Emphasis on the unreliability of the HbA1c as the indicator for glycemic control was 
demonstrated by the provider by pursuing those that were inaccurate (5 out 6). For these patients, the 
FS are the best measure of glycemic control. Vajen et al. (2012) note that treatment plans exclusively 
based on HbA1c without reference to daily glucose logs makes it improbable that evidence-based 
guidelines are being scrupulously adhered to. The FS values are the fail-safe method that pursues the 
discordance between the HbA1c results and FS values. Medications will hopefully not be 
discontinued based on the HbA1c results when in fact, the patient’s FS were uncontrolled. The 
provider now has the awareness to order work-ups for anemia as one option to identify the root 
cause of the discrepant values and to enable timely intervention. This information was of 
significance since the chart audit revealed that 17 out of the 22 patients had CKD. This finding is a 
valuable indicator that the patient may have CKD related anemia which can alter the accuracy of the 
HbA1c results for these patients (Kliger et al., 2013). 
            For the other required T2DM routine care, use of the checklists and standardized order sheets 
that specified the frequency of when the HbA1c, UACr, and RFPs was a decisive solution. Final 
results of the chart audit showed that these labs were now ordered on a routine basis as per the ADA 
guidelines. Order standardization may help lessen the burden for the APRN and provide the staff 
some level of accountability in following the recommended routine care for elderly patients with 
T2DM with poor health conditions. With regards to ophthalmology and podiatry referrals, the 
outcome was poor related to APRN resistance and healthcare coverage restrictions. Of significance, 
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64% (17 out of 22) patients had dementia. Thorpe et al. (2012) found that patients with dementia 
were less likely to receive individual tests such as eye exams. Among the barriers cited were the 
burden imparted on patients and caregivers in scheduling appointments and arranging transportation 
compounded by the fact that cooperation in completing the actual exam may be an impossibility due 
to cognitive deficits. It is important to highlight that the findings supported those of Haugsvedt 
(2016) regarding the presence of discrepancies between diabetes guideline recommendations and 
clinical diabetes practice in LTCFs, individualized treatment goals for HbA1c, and the establishment 
of routine T2DM tests and exams. 
Limitations 
 The QI project has limitations. One limitation was that there was a low rate of participation 
from the nurses. In addition, the management communicated the in-service was not to interfere with 
the routine care of the patients. Hausken and Graue (2012) cited that the success of a diabetes care 
training for nurses in a LTCF is considerably dependent on organizational support of the educational 
program. The in-service was originally scheduled to take place during the monthly staff meeting to 
capture more nurses, but was canceled due to an unscheduled state inspection. The alternate viable 
solution was to approach the nurses on a one-on-one basis at opportune times during their shifts. 
The different educational needs of the nurses based on previous education and clinical 
experience was also not considered and may have affected the total scores on the questionnaires. The 
use of a pre/post-test questionnaire may not necessarily indicate that an improvement in performance 
occurred but rather, measured the nurses’ ability to retain and recall the known facts regarding 
T2DM care in LTCF residents. 
 INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY                                         57 
 
The small sample size of the patients selected for the QI project was also a limitation; but it 
allowed for the QI project to be conducted in a relatively short amount of time and restricted 
financial costs.  
Lastly, the absence of a centralized electronic medical record had a negative impact on the 
annotation of individualized HbA1c targets in the progress notes. Van Doorn-Klomberg et al. (2014) 
found that the use of an electronic patient registry is a positive organizational determinant in the 
provision of high-quality diabetes care. The silver lining for this project was that despite the barriers 
faced by the APRN, she was supportive in the development, implementation, and evaluation of the 
QI project.  
Implications and Recommendations 
 What was derived from this QI project was that an educational in-service regarding 
evidenced-based T2DM care for LTCF residents was needed by nurses. Future endeavors should be 
focused on improving the delivery of preventive eye and foot exams for the residents. The essential 
component to ensure preservation of the resident’s quality of life devoid of any diabetes related 
complications demands collaborative effort from the administration, provider, and nurses. Gershater, 
Pilhammar, and Riojer (2013) cited that the organization must take the responsibility in taking a 
proactive approach in formally educating their nurses. It is counterintuitive that the focus of care is 
provision of acute services for preventable complications. It needs to be communicated to 
management and healthcare staff that preventive care translates to considerable monetary savings for 
the LTCF and better health outcomes for its residents and that an investment in staff education may 
promote these cost savings. 
The implications of the QI project for the APRN in a DNP role is that DNP-prepared APRNs 
are in a prime position to advocate for the delivery of high-quality, evidence-based care which can 
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achieve positive health care outcomes for our patients. A comprehensive presentation of the role of 
the DNP in the interdisciplinary team based on the American Association of Colleges of Nursing 
(AACN) Essentials of Doctoral Education for Advanced Nursing Practice is presented in Table 9. 
The presence of co-morbidities and functional limitations that complicate care in the elderly 
patient with diabetes who resides in LTCF demands the utmost professional competence. As DNP 
prepared APRNs, the ultimate challenge is to improve diabetes care in nursing homes. Among the 
lessons learned from this QI project is that even a miniscule improvement can potentially contribute 
to significant improvements in the LTCF residents’ quality of life and favorable organizational 
support is needed to successfully achieve the objectives of a QI project to allow for its sustainability 
in the long-run. The role of the APRN with a DNP role is to provide the leadership and expertise to 
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Table 9 
Connection of QI project to DNP role 
_____________________________________________________________________________________________ 
Essentials    Connection to DNP Role 
_______________________________________________________________________________________________________ 
Essential I: Scientific Underpinnings  DNPs possess a comprehensive cache of knowledge from other areas  
for Practice    of sciences that strengthens the foundation for exemplary practice 
     rooted in scientific knowledge that facilitates successful planning, 
     implementation, and evacuation of the QI project. 
_____________________________________________________________________________________________ 
Essential II: Organization and Systems   DNPs are tasked with promoting improved health outcomes.  
Leadership for Quality Improvement  Exceptional leadership skills and exhaustive knowledge of the 
and Systems Thinking   processes involved in quality improvement is requisite criteria in order 
     to correct the identified deficiencies in the care of the elderly patients 
     with T2DM in LTCFs. 
_____________________________________________________________________________________________ 
Essential III. Clinical Scholarship  DNPs base translation, application, and evaluation of quality 
and Analytical Methods for   improvement programs from evidenced-based practice to solidify its 
Evidenced-Based Practice   credibility and guarantee positive health outcomes for T2DM elderly  
     patients with co-morbid conditions residing in LTCFs. 
_____________________________________________________________________________________________ 
Essential IV: Information Systems/  Where applicable, DNPs are proficient in the use and application of  
Technology and Patient Care   Information/systems technology that can effect positive changes in our 
Technology for the Improvement  faltering health care system. 
and Transformation of Health Care 
_____________________________________________________________________________________________ 
Essential V: Health Care Policy for  DNPs take a proactive role in influencing health policies that promote 
Advocacy in Health Care   ethical and equitable care for the elderly. Preservation of quality of life 
     and dignity are the fundamental aspects of T2DM care for this 
     vulnerable group. 
_____________________________________________________________________________________________ 
Essential VI: Interprofessional  DNPs are prepared to collaborate with other health care disciplines to  
Collaboration for Improving Patient  achieve the mandate of the Institute of Medicine to achieve safe,  
and Population Outcomes   timely, effective, efficient, equitable, and patient centered care in a 
     complex health care environment. DNPs are expected to assume a 
     leadership role of function as a highly skilled member of the team  
where necessary. 
_____________________________________________________________________________________________ 
Essential VII: Clinical Prevention  DNPs are qualified to meet the national call for health promotion and 
and Population Health for Improving  disease prevention to achieve the national goal of improving the health 
the Nation’s Health    of the population of the U.S. It can be initiated on a small scale at a 
     LTCF in elderly patients with T2DM complicated by co-morbidities. 
_____________________________________________________________________________________________ 
Essential VIII: Advance Nursing  DNPs are primed to function in a variety of health care settings (LTCF) 
Practice     with the distinct capacity to comprehensively integrate requisite  
     knowledge obtained from advance practice training; and apply it to an 
     area of specialized practice (T2DM in the elderly) to affect an 
     improvement in care. 
_____________________________________________________________________________________________ 
Note. Adapted from The Essentials of Doctoral Education for Advanced Nursing Practice. Copyright 
2006 by the American Association of Colleges of Nursing.  
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Appendix A 
Provider and Staff Questionnaire About Routine T2DM Care 
Care of the Elderly with T2DM Questionnaire 
 








3) Are you familiar with the diabetes treatment guidelines pertaining to periodic monitoring of 
complications associated with T2DM such as eye exams, podiatry visits, HbA1c checks, 
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Appendix B  
Demographic Sheet for LTCF Chart Review 
ID #:  _____ Age:  _____ Gender:  _____    
Co-morbid conditions:    
Dementia  ____     CVA/TIA  _____ CAD  _____     PVD  _____ CKD  _____ CHF  _____  
=======================================================================
Lab results: 
HbA1c:   ______________    Dates: _______________ 
 ______________                _______________ 
  ______________                _______________ 
 
Alb/cr:  ______________    Dates:  _______________ 
  ______________                _______________ 
  ______________                _______________ 
 
RFP:   ______________    Dates:  _______________ 
 ______________                 _______________ 
 ______________     _______________ 
=======================================================================
Routine T2DM care: 
Ophthalmology:     Podiatry: 
Dates:  ______________   Dates: ______________ 
  ______________    ______________ 
  ______________    ______________ 
 
Reason: ______________    ______________ 
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Appendix C  
HBA1c Treatment Goals for Older Adults with Diabetes 
Patient characteristics 
/health status 
Rationale Reasonable HbA1c Goal 
Health (few coexisting 
chronic illnesses, intact 
cognitive and functional 
status) 
Longer remaining life 
expectancy 
<7.5% (58 mmol/mol) 
Complex/intermediate 
(multiple coexisting chronic 
illness or 2+ instrumental 
ADL impairments or mild-to 
moderate cognitive 
impairment) 
Intermediate remaining life 
expectancy, high treatment 
burden, hypoglycemia 
vulnerability, and fall risk 
<8.0% (64 mmol/mol) 
Very complex/poor health 
(LTC or end-stage chronic 
illnesses or moderate to 
severe cognitive impairment 
or 2+ ADL dependencies) 
Limited remaining life 
expectancy makes benefit 
uncertain 
<8.5% (69 mmol/mol) 
   
Reminders: 
 Co-existing chronic illnesses are as follows: arthritis, cancer, congestive heart failure, 
depression, emphysema, falls, hypertension, incontinence, stage 3 or worse chronic kidney 
disease, myocardial infarction, and stroke. 
 End-stage-chronic illnesses are defined as stages 3-4 congestive heart failure or oxygen 
dependent lung disease, chronic kidney disease requiring dialysis, or uncontrolled metastatic 
cancer that may cause significant symptoms or impairment of functional status and 
significantly reduce life expectancy. 
 Loose HbA1c targets higher that 8.5% (69 mmol/mol) is not recommended since this 
predisposes the patient to more frequent higher blood sugar values that can lead to 
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Appendix D  
Conditions that Affect the Accuracy of HbA1c 
Conditions Description 
Hemoglobinopathies Any inherited conditions that alter the oxygen-
carrying protein of the red blood cells such as 
sickle cell anemia and thalassemias -> causes 
for HbA1c results to be falsely lower 
Anemias affecting average lifespan 
Hemolytic anemia or bleeding Causes increased red blood cell (RBC) 
production -> more new RBCs relative to entire 
RBC group --> less time for glycosylation -> 
lower HbA1c 
Iron/B12/Folate deficiency Causes decreased RBC production -> fewer 
RBCs relative to entire RBC group -> more time 
for glycosylation -> higher A1c 





 The above clinical conditions will render the HbA1c test unreliable. Use the 
fingersticks as the measure of glycemic control. 
 If a discrepancy between the HbA1c and fingersticks are identified, pursue 
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Appendix E  
LTCF Routine T2DM Checklist. 
MICROVASCULAR COMPLICATION MACROVASCULAR COMPLICATION 
___ Retinopathy/Albuminuria 
___ Overt Nephropathy  ___ Neuropathy 
___ Gastroparesis            ___  Prior Foot 
Ulcer 





_____  Current 
Due: __________  
_____  Please order 
 
Hemoglobin A1c Perform every 3 months 
unless at goal. If patient is at 




_____ Please order 
 
Lipid panel Perform annually. 
_____ Current 
Due: __________ 
_____  Please order 
Urine albumin-to-creatinine 
ratio 
Perform annually. DO NOT 
order if patient has chronic 
kidney disease.  
 
_____  Current 
Due: __________ 
_____  Please order 
 







_____  Please order 
 
Annual dilated and 
comprehensive eye exam 
Perform annually. It may be 
done less frequently (every 2-
3 years) following >1 normal 
exams. 
_____  Current 
Due: __________ 
_____  Please order 
 






_____ Please order 
Review eligibility for flu and 
pneumonia vaccination. 
Perform flu shots annually 
and Pneumonia vaccines as 
per guidelines. (Administer 1-
time dose to PCV13-naïve 
adults at age 65 years,           
followed by a dose of 
PPSV23 12 months later). 
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Appendix F  
Simplified Order Form for Provider 
Standing orders for diabetes mellitus type 2 
LABORATORY TESTS: 
 
⃝     Hemoglobin A1c every 3 months 
 
⃝     Fasting lipid profile every year 
 
⃝     Urine Microalbumin/Creatinine ratio every year (DO NOT order if patient has CKD) 
 




⃝     Influenza vaccine every year (as per facility schedule) 
 
⃝    Pneumonia vaccine (Administer 1-time dose to PCV13-naïve adults at age 65 years,  




⃝     Dilated eye exam every year 
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Appendix G  
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Appendix H 
Pre/Post Learning Assessment Questionnaire 
Pre/Post Test Questionnaire 
1) Diabetes blood sugar targets for older adults must take into consideration that these patients: 
 
 a. Have higher rates of premature death and physical disability 
 b. Are more prone to co-existing illnesses such as hypertension, heart disease, and  
     stroke 
 c. Are significantly at increased risk for common conditions associated with the aging  
     process  
 d. All of the above 
 
2) The HbA1c goal for most patients recommended by the American Diabetes Association 
should be at: 
 
 a. <6.5% 
 b. <6% 
 c. <7.0 
 d. <8% 
 
3) Elderly patients with complex health conditions are at __________ mortality risk with tight 
blood sugar control. 
 
 a. Higher  
 b. Lower 
 
4) Older people do not need to have regular eye exams, foot exams, and tests of kidney 
functioning. 
 
 a. Yes 
 b. No 
 
5) What are two effective ways of lowering the chances of hypoglycemia during transfer of 
older patients from the hospital to long-term care facilities? 
 
 a. Telephone call. 
 b. Written medication dosing information and careful medication reconciliation. 
 c. Face to face conversation between care team members. 
 d. Texts specifying written medication dosing. 
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Appendix H (continued) 
 
6) What would be a reasonable HbA1c goal for a 72-year-old woman with a complex health 







7) What would be a reasonable HbA1c target for an older patient with a history of recurrent 
hypoglycemia, limited life expectancy, multiple co-morbid conditions, advanced chronic 







8) Which of the following conditions increases the risk for hypoglycemia in older adults? 
 
a. Chronic liver disease 
b. Chronic kidney disease 
c. Heart Disease 
d. Gastroparesis 
 





10) The priority for older adults with T2DM is the avoidance and prevention of: 
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Appendix I  
Program Evaluation Form 
Participant Feedback Form 
Date of Session: Date 2017      
Didactic Topic: “Title” 
Please indicate your level of agreement with each 
statement below by checking the appropriate box.  
Add your comments and suggestions  





























































KNOWLEDGE       
I had sufficient knowledge of the discussion topic 
before the presentation/session. 
      
I have sufficient knowledge of the discussion topic 
after the presentation/session. 
      
CONFIDENCE       
I felt confident with regards to the treatment of 
complex diabetes patients before this session. 
      
I feel confident with regards to the treatment of 
complex diabetes patients after this session. 
      
PRACTICE       
I am likely to make changes to my treatment practice 
for patients with diabetes based on what I learned in 
the session today. 
      
COMMENTS/SUGGESTIONS       
The delivery method was appropriate.       
The presenter demonstrated professionalism and 
expertise in the subject area. 
      
What comments or suggestions do you have to help 
us improve this session? 
      
Which best describes your professional background? 
 Physician     NP/CNS/PA    Registered Nurse     
 LVN         Non-medical   
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Appendix J  
LTFC Chart Audit Form 







































1  Medicaid Y Y n/a N n/a N N 
2  Medicaid Y Y n/a N Y/Y N N 
3  Medicaid Y Y N N Y/Y N N 
4  Medicaid Y Y Y N n/a N N 
5  Medicaid Y Y Y N n/a N N 
6  Medicaid Y Y Y N n/a N N 
7  Medicaid Y Y Y Y n/a N N 
8  Medicaid Y Y n/a N n/a N N 
9  Medicaid Y Y n/a N Y/Y N N 
10  Medicaid Y Y n/a N n/a N N 
11  Medicaid Y Y n/a N n/a N N 
12  Medicaid Y Y n/a N n/a N N 
13  Medicaid Y Y n/a N n/a N N 
14  Medicaid Y Y n/a N n/a N N 
15  Medicaid  Y Y n/a Y n/a N N 
16  Medicaid Y Y Y N n/a N N 
17  Medicaid Y Y n/a N n/a N N 
18  Private Y Y n/a N Y/Y N N 
19  Private Y Y N N n/a N N 








































20  Medicaid Y Y n/a N n/a N N 
21  Medicare  Y Y n/a Y Y/Y N N 
22  Medicaid Y Y n/a N n/a N N 
23          
24          
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Appendix K  
Project Timeline  
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Appendix L 
2017 ADA Routine T2DM Care Guidelines 
Laboratory Tests and Why? Frequency 
Hemoglobin A1c (HbA1c) 
measures the amount of glucose attached to 
the red blood cells. I shows the average blood 
sugar level for the past 2-3 months. 
Every three months. 
Urine check for microalbumin (alb/cr) 
checks the urine for small proteins 
(microalbumin) which is a hallmark for early 
kidney damage. 
Once a year. 
 
Lipid Profile 
measures the level of triglycerides and total 
cholesterol. 
Once a year of more often if needed. 
Physical Exams and Why? Frequency 
Retinal eye exam by ophthalmologist 
exam involves taking a picture of the eye with 
a special camera without having to dilate the 
eye to check for signs of nerve damage to the 
eye (retinopathy). 
Once a year for those with retinopathy. 
 
Every 2 years for those who do not have signs 
of retinopathy. 
Foot exam by podiatrist 
checks for foot problems such as calluses, 
bunions, sores, and loss of sensation on the 
feet to allow for early intervention and 
prevent serious complications. 
Once a year. 
 
More often if foot problems are identified. 
Immunizations and Why? Frequency 
Flu and Pneumonia shots 
people with diabetes are at high risk for 
acquiring the flu and pneumonia vaccine 
Every year for flu shot. 
 
Pneumonia: 1 dose of PCV13 and at least 1 
dose of PPSV23 depending on age and health 
status. 
 
 
 
 
 
 
